Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) CEO Jitendra Mohan sold 45,755 shares of the company's stock in a transaction dated Friday, July 18th. The stock was sold at an average price of $100.25, for a total value of $4,586,938.75. Following the transaction, the chief executive officer directly owned 488,131 shares of the company's stock, valued at $48,935,132.75. This represents a 8.57% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Jitendra Mohan also recently made the following trade(s):
- On Thursday, July 17th, Jitendra Mohan sold 80,503 shares of Astera Labs stock. The stock was sold at an average price of $94.37, for a total value of $7,597,068.11.
- On Thursday, July 10th, Jitendra Mohan sold 11,282 shares of Astera Labs stock. The stock was sold at an average price of $102.46, for a total value of $1,155,953.72.
- On Wednesday, July 9th, Jitendra Mohan sold 6,982 shares of Astera Labs stock. The stock was sold at an average price of $100.01, for a total value of $698,269.82.
- On Friday, June 20th, Jitendra Mohan sold 52,743 shares of Astera Labs stock. The stock was sold at an average price of $100.86, for a total transaction of $5,319,658.98.
- On Tuesday, June 17th, Jitendra Mohan sold 106,510 shares of Astera Labs stock. The shares were sold at an average price of $94.54, for a total transaction of $10,069,455.40.
- On Thursday, May 29th, Jitendra Mohan sold 14,200 shares of Astera Labs stock. The shares were sold at an average price of $100.00, for a total transaction of $1,420,000.00.
- On Monday, May 19th, Jitendra Mohan sold 128,250 shares of Astera Labs stock. The stock was sold at an average price of $90.02, for a total transaction of $11,545,065.00.
- On Friday, May 16th, Jitendra Mohan sold 91,337 shares of Astera Labs stock. The stock was sold at an average price of $90.67, for a total transaction of $8,281,525.79.
- On Wednesday, May 14th, Jitendra Mohan sold 75,000 shares of Astera Labs stock. The shares were sold at an average price of $90.90, for a total transaction of $6,817,500.00.
- On Thursday, May 8th, Jitendra Mohan sold 75,000 shares of Astera Labs stock. The shares were sold at an average price of $71.05, for a total transaction of $5,328,750.00.
Astera Labs Stock Down 4.1%
NASDAQ:ALAB traded down $4.98 during trading hours on Tuesday, hitting $116.91. 7,674,540 shares of the company traded hands, compared to its average volume of 4,492,860. The firm's 50-day simple moving average is $92.81 and its 200-day simple moving average is $86.33. Astera Labs, Inc. has a one year low of $36.22 and a one year high of $147.39. The company has a market cap of $19.28 billion, a PE ratio of 531.43, a PEG ratio of 4.79 and a beta of 1.18.
Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.05. The firm had revenue of $159.44 million during the quarter, compared to analyst estimates of $151.55 million. Astera Labs had a return on equity of 2.57% and a net margin of 8.44%. The business's revenue was up 144.1% compared to the same quarter last year. During the same period last year, the firm posted $0.10 EPS. As a group, equities research analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Astera Labs by 2,824.4% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 154,524 shares of the company's stock valued at $20,467,000 after acquiring an additional 149,240 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Astera Labs by 50.5% in the fourth quarter. JPMorgan Chase & Co. now owns 2,360,467 shares of the company's stock valued at $312,644,000 after purchasing an additional 792,153 shares during the last quarter. Pacific Point Advisors LLC grew its stake in Astera Labs by 75.0% in the first quarter. Pacific Point Advisors LLC now owns 7,000 shares of the company's stock valued at $418,000 after purchasing an additional 3,000 shares during the last quarter. Oppenheimer Asset Management Inc. grew its stake in Astera Labs by 73.6% in the first quarter. Oppenheimer Asset Management Inc. now owns 15,995 shares of the company's stock valued at $954,000 after purchasing an additional 6,783 shares during the last quarter. Finally, Taylor Frigon Capital Management LLC purchased a new position in Astera Labs in the first quarter valued at about $1,887,000. 60.47% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research analysts have weighed in on the company. Needham & Company LLC reduced their price target on Astera Labs from $140.00 to $100.00 and set a "buy" rating on the stock in a research note on Wednesday, May 7th. Barclays boosted their price target on shares of Astera Labs from $70.00 to $75.00 and gave the company an "overweight" rating in a report on Wednesday, May 7th. Northland Securities downgraded shares of Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 target price for the company. in a research report on Tuesday. Susquehanna assumed coverage on shares of Astera Labs in a research report on Friday, May 16th. They issued a "neutral" rating and a $80.00 price target on the stock. Finally, Stifel Nicolaus increased their price objective on shares of Astera Labs from $100.00 to $110.00 and gave the stock a "buy" rating in a report on Friday. Three analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Astera Labs has an average rating of "Moderate Buy" and a consensus price target of $102.67.
Check Out Our Latest Analysis on Astera Labs
Astera Labs Company Profile
(
Get Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Further Reading

Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.